期刊文献+

加替沙星三联治疗幽门螺杆菌疗效观察

下载PDF
导出
摘要 目的研究加替沙星与泮托拉唑为基础的三联疗法根除幽门螺杆菌(Hp)的疗效,不良反应,以探讨临床更佳的根除Hp方案。方法选择符合条件的62例,随机分为治疗组和对照组,每组各31例。治疗组给予甲磺酸加替沙星200mg,2次/d,甲硝唑0.4g,2次/d,泮托拉唑纳肠溶胶囊40mg,1次/d;对照组给予阿莫西林1.0,2次/d,甲硝唑0.4,2次/d,泮托拉唑纳肠溶胶囊40mg,1次/d;疗程为14d。停药后4周复查胃镜或14C尿素呼气试验。结果治疗组Hp根除率87%;对照组Hp根除率90%。两组无统计学差异(P>0.05)。结论加替沙星与泮托拉唑为基础的三联疗法能有效,安全的根除Hp,不良反应小。
作者 王莉
出处 《中国现代药物应用》 2009年第16期112-113,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献4

二级参考文献17

  • 1CAMMAROTA G, CIANCI R, CANNIZZARO O, et al. High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levefloxacin, for Helicobacter pylorieradication [J].J Clin Gastroenterol, 2004,38 (2): 110-114.
  • 2BOSQUES-PADILLA FJ, GARZA-GONZALEZ E, CALDERONLOZANO IE, et al. Open, randomized multicenter comparative trial of rabeprazole, ofloxacin and amoxicillin therapy for Helicobacter pylori eradication:7 vs 14 day treatment [J]. Helicobacter, 2004,9(5) :417-421.
  • 3FISH DN, NORTH DS. Gatifloxacin, an advanced 8-methory fluoroquinolone [J]. Pharmacotherapy, 2001,21 (1) :35-59.
  • 4SARAVOLATZ LD, LEGGETT J. Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolone [J]. Clin Infect Dis, 2003,37(9) :1210-1215.
  • 5KHURANA A, VINAYEK N, RECCO RA, et al. The incidence of clostridium diffile-associated and non-C. diffile-associated doarrhea after use of gatifloxacin and levofloxacin in an acute-care facility [J]. Clin Infect Dis, 2004,39(4) :602-603.
  • 6GRASELA DM, CHRISTOFALO B, KOLLIA GD, et al. Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment [J]. Pharmacotherapy,2000,20 (6Pt2) :87S-94S.
  • 7HENANN NE, ZAMBIE MF. Gatifloxacin-asociated acute hepatitis [J]. Pharmacotherapy, 2001,21 (12): 1579-1582.
  • 8CHEUNG O, CHOPRA K, YU T, et al. Gatifloxacin-induced hepatotoxicity and acute pancreatitis [J]. Ann Intern Med, 2004,140(1) :73-74.
  • 9LOMAESTRO BM. Fluoroquinolone-induced renal failure [J].Drug Saf, 2000,22(6) :479-485.
  • 10LEBLANC M, BELANGER C, COSSETTE P. Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy [J]. Pharmacotherapy, 2004,24 (7) :926-931.

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部